(Press-News.org) How immune cells deliver their deadly cargo
When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the release of toxic granules – microscopic packages that destroy virus-infected or cancerous cells. The study led by researchers from CeMM, St. Anna CCRI, MedUni Vienna, Med Uni Graz, the University Hospital Bonn (UKB) and the University of Bonn, published in Science Immunology (DOI: 10.1126/sciimmunol.ado3825), uncovers an unexpected link between lipid metabolism and the immune system’s ability to deliver its lethal cargo, offering new insights into diseases caused by genetic defects.
Our immune system relies on specialized cells, such as natural killer (NK) cells and T cells, to find and destroy dangerous invaders like viruses or cancer cells. To do this, they release “packages” filled with powerful molecules – so-called cytotoxic granules – that kill infected or cancerous cells. Although some key molecules have been identified through immune disorders and their effects, others that might be important for this release mechanism are still unknown.
In their new study published in the renowned journal Science Immunology (DOI: 10.1126/sciimmunol.ado3825) a team of scientists led by Kaan Boztug, Professor at the Medical University of Vienna, Principal Investigator at the St. Anna Children’s Cancer Research Institute, Adjunct Principal Investigator at the CeMM Research Center for Molecular Medicine as well as Director of the Clinic for Pediatric Immunology and Rheumatology at UKB and member of the ImmunoSensation2 Cluster of Excellence at the University of Bonn, together with Artem Kalinichenko, Assistant Professor at the Medical University of Graz and former Senior Postdoc at St. Anna CCRI and CeMM as well as Jakob Huemer, former PhD Student at CeMM, (both former members of the research group of Kaan Boztug), has made a discovery that changes the way we understand how our immune system fights disease.
By using a CRISPR-based genetic screening approach, the researchers identified a set of unexpected genes that play a key role for the precise release of cytotoxic granules in human NK and T cells. Surprisingly, many of these genes are connected to cellular lipid metabolism. The team discovered that specific lipids help guide important proteins to the right place inside immune cells, including targeted release of cytotoxic granules and the delivery of their deadly packages to keep the body safe.
This breakthrough not only helps explain how immune cells work but also sheds light on diseases caused by genetic defects, such as certain rare nerve disorders and inherited immune problems. “By systematically exploring genetic pathways and combining functional genomics with mechanistic follow-up, we have uncovered a new group of genes that control how T and NK cells function and kill both virus-infected cells or tumor cells,” says co-first author Artem Kalinichenko.
“It’s fascinating to see how molecules originally known from neuronal biology and associated with lipid metabolism and modification are also key for a distinct immune defense mechanism,” adds Jakob Huemer, co-first author of the study. “Our findings open up new questions about how shared cellular pathways shape very different biological systems.”
“This work showcases the power of collaborative, curiosity-driven research,” concludes senior author Kaan Boztug. “We were able to uncover a completely unexpected connection between lipid biology and immune cell function and thereby link seemingly unrelated biological processes. These findings will further help us improve diagnosis of patients with rare immune defects, and are also relevant for future development of cancer immunotherapy approaches.”
The research was carried out in international collaboration with teams from Austria, France, Sweden, and Finland, and represents an important step forward in understanding how our bodies fight infections and cancer.
---
The CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences is an international, independent and interdisciplinary research institution for molecular medicine under the scientific direction of Giulio Superti-Furga. CeMM is oriented towards medical needs and integrates basic research and clinical expertise to develop innovative diagnostic and therapeutic approaches for precision medicine. Research focuses on cancer, inflammation, metabolic and immune disorders, rare diseases and aging. The Institute's research building is located on the campus of the Medical University and the Vienna General Hospital. www.cemm.at
St. Anna Children’s Cancer Research Institute (St. Anna Kinderkrebsforschung, St. Anna CCRI) is an international and interdisciplinary research institution dedicated to developing innovative diagnostic, prognostic, and therapeutic strategies for the treatment of children and adolescents with cancer. Taking into account the specific features of childhood tumors, dedicated research groups in tumor genomics and epigenomics, immunology, molecular and cell biology, bioinformatics, and clinical research work together to align the latest scientific findings with clinical needs and sustainably improve the well-being of young patients.
www.ccri.at | www.kinderkrebsforschung.at
The Medical University of Vienna (MedUni Vienna) is one of the longest-established medical education and research facilities in Europe. With almost 8,600 students, it is currently the largest medical training center in the German-speaking countries. With more than 6,500 employees, 30 departments and two clinical institutes, twelve medical theory centers and numerous highly specialized laboratories, it is one of Europe's leading research establishments in the biomedical sector. MedUni Vienna also has a medical history museum, the Josephinum. www.meduniwien.ac.at
As one of Germany’s leading university hospitals, the University Hospital Bonn (UKB) combines top performance in medicine and research with excellence in teaching. Each year, more than half a million patients receive inpatient and outpatient care at the UKB. Around 3,500 students are enrolled in medicine and dentistry, and more than 600 people are trained annually in healthcare professions. With approximately 9,900 employees, the UKB is the third-largest employer in the Bonn/Rhine-Sieg region. In the Focus hospital ranking, the UKB ranks first among university hospitals in North Rhine-Westphalia and has the second-highest case-mix index nationwide. In 2024, the UKB secured nearly €100 million in third-party funding for research, development, and teaching. The F.A.Z. Institute has named the UKB “Germany’s Training Champion” and “Germany’s Most Sought-After Employer” for the fourth consecutive year. Current figures can be found in the annual report at: geschaeftsbericht.ukbonn.de
The Medical University of Graz (Med Uni Graz) is one of Austria’s leading institutions for medical education and biomedical research. With around 2,500 employees and more than 2,600 students, MedUni Graz combines cutting-edge research, innovative teaching, and patient-oriented clinical practice. The university has a particular focus on metabolism in health and disease, alongside strong research programs in cancer, cardiovascular and metabolic disorders, neuroscience, and immunology, supported by state-of-the-art core facilities and interdisciplinary research centers. www.ukbonn.de/
END
How immune cells deliver their deadly cargo
2025-10-17
ELSE PRESS RELEASES FROM THIS DATE:
How the brain becomes a better listener: How focus enhances sound processing
2025-10-17
When we are engaged in a task, our brain’s auditory system changes how it works. One of the main auditory centers of the brain, auditory cortex, is filled with neural activity that is not sound driven – rather, this activity times the task, each neuron ticking at a different moment during task performance.
Researchers at Hebrew University have discovered how this happens. The study, led by Prof. Israel Nelken from the Edmond and Lily Safra Center for Brain Sciences (ELSC) and the Institute of Life Sciences, is based on the PhD research of Ana Polterovich, with contributions from Alex Kazakov, Maciej M. Jankowski, and Johannes Niediek.
They ...
Processed fats found in margarines unlikely to affect heart health
2025-10-17
Two types of industrially processed hard fats, widely used in everyday foods such as bakery products, margarines and spreads, are unlikely to affect heart health when consumed in levels achievable in most people’s diets.
The study, led by researchers at King’s College London and Maastricht University and published in the American Journal of Clinical Nutrition, investigated the health effects of interesterified (IE) fats which are rich in either palmitic acid (from palm oil) or stearic acid (from other plant fats).
These fats are often used by the food industry as alternatives to other hard fats, including trans fats and animal fats, which have known risks to ...
Scientists discover how leukemia cells evade treatment
2025-10-17
Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients – and found a potential way to overcome that resistance.
Team members identified a protein that lets cancer cells reshape their energy-producing mitochondria in ways that protect them from venetoclax (brand name, Venclexta), a standard treatment for acute myeloid leukemia that often loses effectiveness after prolonged use.
Blocking that protein with experimental compounds in mice with human acute myeloid leukemia restored the drug's effectiveness and ...
Sandra Shi MD, MPH, named 2025 STAT Wunderkind
2025-10-17
Sandra Shi MD, MPH, has been named a 2025 STAT Wunderkind. Dr. Shi is a geriatrician, instructor in medicine at Harvard Medical School, and assistant scientist at the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife.
STAT Wunderkinds is a chance to celebrate early-career researchers who are not yet independent scientists or program leaders. It honors postdoctoral researchers, interns, and fellows — those who have terminal degrees in hand, but aren’t ...
Treating liver disease with microscopic nanoparticles
2025-10-17
Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease Control and Prevention reports that it kills more than 52,000 people a year in the United States alone — the ninth most common cause of death in the nation.
Despite this significant impact on society, alcohol-related liver disease (ARLD) remains largely unaddressed by medical research. Texas A&M University researcher Dr. Jyothi Menon aims to change that with a promising new therapy that she’s developing. ...
Chemicals might be hitching a ride on nanoplastics to enter your skin
2025-10-17
Plastic is ubiquitous in the modern world, and it’s notorious for taking a long time to completely break down in the environment — if it ever does.
But even without breaking down completely, plastic can shed tiny particles — called nanoplastics because of their extremely small size — that scientists are just now starting to consider in long-term health studies.
One of those scientists is Dr. Wei Xu, an associate professor in the Texas A&M College of Veterinary Medicine and Biomedical Sciences’ Department of Veterinary Physiology & Pharmacology. Xu’s ...
Pregnant patients with preexisting high cholesterol may have elevated CV risk
2025-10-17
Preexisting hyperlipidemia in pregnancy is associated with heightened risks of obstetric complications and early cardiovascular events in the first five-years postpartum, according to a new study being presented at ACC’s Cardio-Obstetrics Essentials: Team-Based Management of Cardiovascular Disease and Pregnancy conference. The researchers call for clinicians to incorporate lipid screening into preconception care and closely monitor women with hyperlipidemia during and after pregnancy.
“Pre-pregnancy hyperlipidemia is not just a metabolic concern; it ...
UC stroke experts discuss current and future use of AI tools in research and treatment
2025-10-17
As artificial intelligence (AI) use continues to grow in nearly every industry, it is important to establish guardrails to make sure the technology is used ethically and responsibly. This is especially true in the field of medicine, where errors can be a matter of life and death and patient information must be protected.
A group of stroke physicians, researchers and industry representatives discussed the current use and future of AI in stroke clinical trial design at the Stroke Treatment Academic Industry Roundtable meeting March 28. Led by the University of Cincinnati’s Joseph Broderick, MD, the researchers published an article in the ...
The Southern Ocean’s low-salinity water locked away CO2 for decades, but...
2025-10-17
Climate models suggest that climate change could reduce the Southern Ocean’s ability to absorb carbon dioxide (CO2). However, observational data actually shows that this ability has seen no significant decline in recent decades. In a recent study, researchers from the Alfred Wegener Institute have discovered what may be causing this. Low-salinity water in the upper ocean has typically helped to trap carbon in the deep ocean, which in turn has slowed its release into the atmosphere – until now, that is, because climate change is increasingly altering the Southern Ocean and its function as a carbon sink. The study ...
OHSU researchers develop functional eggs from human skin cells
2025-10-17
Researchers at Oregon Health & Science University have accomplished a unique proof of concept to treat infertility by turning skin cells into eggs capable of producing early human embryos.
The research published today in the journal Nature Communications.
The development offers a potential avenue for in vitro gametogenesis — the process of creating gametes — to treat infertility for women of advanced maternal age or those who are unable to produce viable eggs due to previous treatment of cancer or other causes.
“In addition to offering hope for millions of people with infertility due to ...